Merck & Co. (MRK)
(Delayed Data from NYSE)
$116.60 USD
+0.05 (0.04%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $116.55 -0.05 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 37% (93 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.23 | 1.97 | 9.99 |
Current Quarter Estimate | 1.72 | 37.72 | 61.00 |
Year Ago Quarter Estimate | 2.13 | 12.41 | 54.84 |
Next Quarter Estimate | 1.95 | 38.19 | 63.00 |
Next Year Estimate | 9.76 | 173.19 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 438.41 | 6.50 | 15.67 |
Next Year | 20.05 | 16.00 | 11.34 |
Last 5 Years | -19.90 | 2.90 | 8.10 |
Next 5 Years | 9.00 | 11.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 17.91 | 22.14 |
Price/Book (MRQ) | 6.77 | 6.10 |
Price/Cash Flow (MRFY) | 38.33 | 11.96 |
Dividend Yield | 2.64% | 2.10% |
Net Profit Margin (TTM) | 21.99% | 18.86% |
Return on Equity (TTM) | 40.69% | 34.56% |
Debt to Equity (MRQ) | 0.80 | 39.86 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.